Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Ferrara

Showing results (451-460 of 566) with videos related to

Pageof 57
Sort By:
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|March 26, 2003
Lowered-intensity preparative regimen for allogeneic stem cell transplantation delays acute graft-versus-host disease but does not improve outcome for advanced hematologic malignancyJohn E Levine, Joseph P Uberti, Lois Ayash, et al.
Virology Journal|June 13, 2023
Transient plasma viral rebound after SARS-CoV-2 vaccination in an exceptional HIV-1 elite controller womanL Di Girolamo, M Ferrara, G Trevisan, et al.
Advances in Experimental Medicine and Biology|January 1, 1990
(S)-1-(3-hydroxy-2-(phosphonylmethoxy)propyl)cytosine (HPMPC): a potent antiherpesvirus agentJ J Bronson, L M Ferrara, M J Hitchcock, et al.
Journal of the American Academy of Dermatology|August 12, 2009
Extracorporeal photopheresis: past, present, and futureRobert Knobler, Mark L Barr, Daniel R Couriel, et al.
Journal of Endocrinological Investigation|June 23, 2009
Mutations in TAZ/WWTR1, a co-activator of NKX2.1 and PAX8 are not a frequent cause of thyroid dysgenesisA M Ferrara, L De Sanctis, G Rossi, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 11, 2008
Plasma elevations of tumor necrosis factor-receptor-1 at day 7 postallogeneic transplant correlate with graft-versus-host disease severity and overall survival in pediatric patientsCarrie L Kitko, Sophie Paczesny, Gregory Yanik, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|October 24, 2007
A novel role for the semaphorin Sema4D in the induction of allo-responsesRaimon Duran-Struuck, Isao Tawara, Kathi Lowler, et al.
Blood|March 3, 2012
Acute graft-versus-host disease biomarkers measured during therapy can predict treatment outcomes: a Blood and Marrow Transplant Clinical Trials Network studyJohn E Levine, Brent R Logan, Juan Wu, et al.
Blood|October 24, 2002
Donor pretreatment with progenipoietin-1 is superior to granulocyte colony-stimulating factor in preventing graft-versus-host disease after allogeneic stem cell transplantationKelli P A MacDonald, Vanessa Rowe, Cheryl Filippich, et al.
Bone Marrow Transplantation|January 26, 2006
Recommended screening and preventive practices for long-term survivors after hematopoietic cell transplantation: joint recommendations of the European Group for Blood and Marrow Transplantation, Center for International Blood and Marrow Transplant Research, and the American Society for Blood and Marrow Transplantation (EBMT/CIBMTR/ASBMT)J D Rizzo, J R Wingard, A Tichelli, et al.
Pageof 57

Showing results (451-460 of 566) with videos related to

Sort By:
Pageof 57
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|March 26, 2003
Lowered-intensity preparative regimen for allogeneic stem cell transplantation delays acute graft-versus-host disease but does not improve outcome for advanced hematologic malignancyJohn E Levine, Joseph P Uberti, Lois Ayash, et al.
Virology Journal|June 13, 2023
Transient plasma viral rebound after SARS-CoV-2 vaccination in an exceptional HIV-1 elite controller womanL Di Girolamo, M Ferrara, G Trevisan, et al.
Advances in Experimental Medicine and Biology|January 1, 1990
(S)-1-(3-hydroxy-2-(phosphonylmethoxy)propyl)cytosine (HPMPC): a potent antiherpesvirus agentJ J Bronson, L M Ferrara, M J Hitchcock, et al.
Journal of the American Academy of Dermatology|August 12, 2009
Extracorporeal photopheresis: past, present, and futureRobert Knobler, Mark L Barr, Daniel R Couriel, et al.
Journal of Endocrinological Investigation|June 23, 2009
Mutations in TAZ/WWTR1, a co-activator of NKX2.1 and PAX8 are not a frequent cause of thyroid dysgenesisA M Ferrara, L De Sanctis, G Rossi, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 11, 2008
Plasma elevations of tumor necrosis factor-receptor-1 at day 7 postallogeneic transplant correlate with graft-versus-host disease severity and overall survival in pediatric patientsCarrie L Kitko, Sophie Paczesny, Gregory Yanik, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|October 24, 2007
A novel role for the semaphorin Sema4D in the induction of allo-responsesRaimon Duran-Struuck, Isao Tawara, Kathi Lowler, et al.
Blood|March 3, 2012
Acute graft-versus-host disease biomarkers measured during therapy can predict treatment outcomes: a Blood and Marrow Transplant Clinical Trials Network studyJohn E Levine, Brent R Logan, Juan Wu, et al.
Blood|October 24, 2002
Donor pretreatment with progenipoietin-1 is superior to granulocyte colony-stimulating factor in preventing graft-versus-host disease after allogeneic stem cell transplantationKelli P A MacDonald, Vanessa Rowe, Cheryl Filippich, et al.
Bone Marrow Transplantation|January 26, 2006
Recommended screening and preventive practices for long-term survivors after hematopoietic cell transplantation: joint recommendations of the European Group for Blood and Marrow Transplantation, Center for International Blood and Marrow Transplant Research, and the American Society for Blood and Marrow Transplantation (EBMT/CIBMTR/ASBMT)J D Rizzo, J R Wingard, A Tichelli, et al.
Pageof 57